DRKS00013922
Completed
N/A
Early Palliative Care for patients with symptomatic Heart Failure - EPCHF
niklinik BonnMedizinische Klinik II0 sites206 target enrollmentMarch 16, 2018
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- I50.12
- Sponsor
- niklinik BonnMedizinische Klinik II
- Enrollment
- 206
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \=18 years
- •\- NYHA class II\-IV symptoms (suspected cardiac dyspnea)
- •\- Systolic HF with a LVEF \=35% or HF with preserved ejection fraction (NYHA class II\-IV, elevated natriuretic peptides (NP), left ventricular hypertrophy (LVH) or left atrial enlargement (LAE) or diastolic dysfunction
- •\- BNP \=100 pg/mL or NT proBNP \=400 pg/mL
- •\- Subjects with the ability to follow study instructions and likely to attend and complete all required visits
- •\- Written informed consent
Exclusion Criteria
- •\- Inability to read, understand and respond to questions in German
- •\- Previous consultations of palliative care services
- •\- Patients in intensive care unit, on a ventilator, pre\- or post\-heart transplant
- •\- Non\-cardiac terminal illness
- •\- Women who are pregnant or planning to become pregnant, nursing women
- •\- Simultaneously participation in another study or participation in any study involving administration of an investigational medicinal product within 30
- •days prior to study beginning
- •\- Subjects with a physical or psychiatric condition which at the investigator’s discretion may put the subject at risk, may confound the trial results, or
- •may interfere with the subject’s participation in this study
- •\- Known or persistent abuse of medication, drugs or alcohol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility studyAdvanced Lung CancerJPRN-UMIN000012772ational Cancer Center Hospital East50
Completed
N/A
Early Palliative Care – Health services research and implementation of sustainable changesC34center-specific tumor entitiesC15C16C25Malignant neoplasm of bronchus and lungMalignant neoplasm of oesophagusMalignant neoplasm of stomachMalignant neoplasm of pancreasDRKS00006162Klinik für Pallliativmedizin, Universitätsklinikum Freiburg592
Not Yet Recruiting
Phase 2
A clinical trial to study the effect of starting early palliative care with chemotherapy at diagnosis of advanced sarcoma compared to chemotherapy alone.CTRI/2019/05/019367VIKAS GARG
Completed
N/A
A randomised phase 3 trial of Palliative care Early in Advanced Lung Cancers.Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Adults with advanced thoracic malignancy (NSCLC, SCLC orMPM) that have been newly diagnosed within the last 60 days.Cancer - Lung - Small cellCancer - Lung - Non small cellCancer - Lung - MesotheliomaACTRN12617000166370niversity of Sydney113
Completed
N/A
Palliative care for patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized studyEsophageal, pancreatic or hepatobiliairy cancerCancerOesophageal cancer, pancreatic cancer, hepatobiliairy cancerISRCTN86515732Health Care Research Program Erasmus MC 2003 (The Netherlands)150